Cui, Liqiang
Zhu, Man
Wang, Tianlin
Gao, Ao
Zhao, Pengzhi
Xiao, Jing
Guo, Daihong
Funding for this research was provided by:
the Project of Monitoring and Evaluation of the Use of Key Clinical Drugs” commissioned by the Chinese Association of Research Hospitals (No. Y2024FH-YWPJ02)
the Key Project of Medical Innovation Project in 2017 (No. 17CXZ010)
Article History
Received: 18 April 2025
Accepted: 17 July 2025
First Online: 19 August 2025
Declarations
:
: The authors declare no competing interests.
: The study protocol was reviewed and approved by the Ethics Committee of the Chinese People’s Liberation Army General Hospital in Beijing, China (approval no. S2018-054-01, approval date May 31, 2018).